EFFECT OF INTERVAL HYPOXYTHERAPY ON THE IMMUNE STATUS OF HYPERTENSIVE PATIENTS
- Authors: Borukaeva I.1, Abazova Z.1, Ivanov A.1, Shkhagumov K.1, Shavaeva F.1, Molov A.1, Tkhabisimova I.1, Kipkeeva T.1, Shokueva A.1, Ashagre S.1, Ligidova D.1, Kugotov A.2
-
Affiliations:
- Kabardino-Balkarian State University named after Kh.M. Berbekov
- I.M. Sechenov First Moscow State Medical University
- Section: Joint Immunology Forum 2024
- URL: https://rusimmun.ru/jour/article/view/16833
- DOI: https://doi.org/10.46235/1028-7221-16833-EOI
- ID: 16833
Cite item
Full Text
Abstract
In recent years, the role of sluggish nonspecific inflammation in the pathogenesis of hypertension has been proven. Oxidative stress that develops in hypertension leads to damage of endothelial glycocalyx with impaired barrier and adaptive functions of endothelium. Activation of transcription factor NF-kB leads to increased synthesis of free oxygen radicals, adhesion molecules (VCAM-1, ICAM-1, P-selectin, E-selectin) and proinflammatory cytokines (TNFα, IL-1, IL-6), triggering the inflammatory process in the endothelium. Modern antihypertensive drugs, affecting various pathogenetic mechanisms of arterial hypertension development, do not fully affect the immune component of arterial hypertension. Therefore, the search for various methods affecting the immunologic reactivity of hypertensive patients remains relevant in our time. The aim of the study was to reveal the effect of interval hypoxytherapy on the state of immunologic reactivity of patients with hypertension stage I. Methods. 170 male patients of 30-45 years old (mean age 38,36±1,64 years) with hypertension stage I (n=170) who underwent combined treatment including drug therapy and normobaric interval hypoxic therapy in hypoxia-normoxia mode (oxygen content in hypoxic gas mixture was 20,9%) were examined. Indices of redox status and immunologic reactivity before and after interval hypoxytherapy were studied. Results. Having a significant antioxidant effect, interval hypoxytherapy led to the subsidence of oxidative stress, which was indicated by an increase in the activity of superoxide dismutase and glutathione peroxidase in blood erythrocytes and a decrease in the content of malonic dialdehyde in blood as a result of a decrease in the generation of free oxygen radicals and suppression of lipid peroxidation processes. Interval hypoxytherapy resulted in a statistically significant increase in the initially decreased content of CD3+ T-lymphocytes (p<0.05), CD3+CD4+ T-lymphocytes (p<0.02), CD3+CD8+ T-lymphocytes (p<0.02). Initially increased number of B-lymphocytes CD19+, CD16+ lymphocytes, CD95+ lymphocytes significantly decreased. An important result of interval hypoxytherapy was a pronounced anti-inflammatory effect: statistically significant decrease in the content of pro-inflammatory interleukins IL-1β (p<0,02), IL-6 (p<0,01) and increase in the content of anti-inflammatory cytokines IL-4 (p<0,005) and IL-10 (p<0,005), which led to the subsidence of sluggish nonspecific inflammation. Conclusions. Suppression of oxidative stress and normalization of immunological reactivity of hypertensive patients after interval hypoxytherapy led to the subsidence of sluggish nonspecific inflammation, reduction of endothelial dysfunction and restoration of the structure and tone of the vascular wall with a decrease in blood pressure and improvement of the clinical course of hypertension.
About the authors
Irina Borukaeva
Kabardino-Balkarian State University named after Kh.M. Berbekov
Email: zalina.abazova@mail.ru
ORCID iD: 0000-0003-1180-228X
PhD, MD (Medicine), Associate Professor, Head of the Department of Normal and Pathological Human Physiology
Russian FederationZalina Abazova
Kabardino-Balkarian State University named after Kh.M. Berbekov
Email: laulau27@mail.ru
PhD (Medicine), Associate Professor of the Department of Normal and Pathological Human Physiology
Anatoly Ivanov
Kabardino-Balkarian State University named after Kh.M. Berbekov
Email: zalina.abazova@mail.ru
PhD, MD (Biology), Professor of the Department of Normal and Pathological Human Physiology
Kazbek Shkhagumov
Kabardino-Balkarian State University named after Kh.M. Berbekov
Email: laulau27@mail.ru
PhD (Medicine), Associate Professor of the Department of Normal and Pathological Human Physiology
Fatima Shavaeva
Kabardino-Balkarian State University named after Kh.M. Berbekov
Email: laulau27@mail.ru
PhD (Biology), Associate Professor of the Department of Normal and Pathological Human Physiology
Anzor Molov
Kabardino-Balkarian State University named after Kh.M. Berbekov
Email: zalina.abazova@mail.ru
PhD (Biology), Associate Professor of the Department of Normal and Pathological Human Physiology
Irina Tkhabisimova
Kabardino-Balkarian State University named after Kh.M. Berbekov
Email: laulau27@mail.ru
hD (Medicine), Associate Professor, Head of the Department of General Medical Training and Medical Rehabilitation
Tatiana Kipkeeva
Kabardino-Balkarian State University named after Kh.M. Berbekov
Email: laulau27@mail.ru
Senior Lecturer of the Department of Normal and Pathological Human Physiology
Asiyat Shokueva
Kabardino-Balkarian State University named after Kh.M. Berbekov
Email: laulau27@mail.ru
Senior Lecturer of the Department of Normal and Pathological Human Physiology of the Medical Academy
Saron Ashagre
Kabardino-Balkarian State University named after Kh.M. Berbekov
Email: zalina.abazova@mail.ru
an assistant professor of the Department of Normal and Pathological Human Physiology of the Medical Academy
Diana Ligidova
Kabardino-Balkarian State University named after Kh.M. Berbekov
Email: zalina.abazova@mail.ru
4th year student of the Institute of Dentistry and Maxillofacial Surgery
Azret Kugotov
I.M. Sechenov First Moscow State Medical University
Author for correspondence.
Email: laulau27@mail.ru
6th year student student
References
- Abazova Z.H., Shibzukhova L.A., Borukaeva I.H., Shibzukhov T.A., Borukaeva L.A. Hypoxytherapy in correction of neurological disorders in children and adolescents with autoimmune thyroiditis. Russian Herald of Perinatology and Pediatrics. 2020, Vol. 65, no. 4, p. 321.
- Amirova A.R., Iskandarova L.R., Mingazetdinova L.N. Immune system as a predictor of endothelial dysfunction in arterial hypertension with metabolic disorders. Fundamental Research. 2006, no. 5, pp. 92-93.
- Barsukov A.V., Talantzeva M.S., Korovin A.E., Mirohina M.A., Dydyshko V.T., Vasiliev V.N. Essential hypertension and inflammation. 2013, Vol. 44, no. 4, pp. 229-235.
- Borukaeva I.Kh., Abazova Z.Kh., Ivanov A.B., Misirova I.A., Shkhagumov K.Yu., Shavaeva F.V., Mоlov A.A., Kipkeeva T.B., Shokueva A.G. Preservation of the immunomodulatory effect of interval hypoxytherapy after coronavirus infection in the long-term period. Medical Immunology. 2023, Vol. 25, no. 4, pp. 809-814.
- Borukaeva I.Kh., Abazova Z.Kh, Ivanov A.B., Shkhagumov K.Yu. The role of interval hypoxytherapy and enteral oxygen therapy in the rehabilitation of the patients presenting with chronic obstructive pulmonary disease. Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury. 2019, Vol. 96, no. 2, pp. 27-32.
- Vasilets L.M., Grigoriadi N.E., Gordiychuk R.N., Karpunina N.S., Krivaya A.A., Scherbenev V.M. Features of systemic inflammation indicators in patients with arterial hypertension. Modern problems of science and education. 2012, no. 6. URL: https://science-education.ru/ru/article/view?id=7539 (accessed on 15.03.2024).
- Vaulin N.A. Endothelial dysfunction in arterial hypertension: focus on nebivolol. Systemic hypertension. 2009, no.1, pp. 11-14.
- Gavrilyuk EV, Konoplya AI, Karaulov AV. Rol immunnykh narusheniy v patogeneze arterialnoy gipertonii. Obzor. Immunology. 2016, Vol. 37, no. 1, pp. 29-36.
- Ziganshina M.M., Ziganshin A.R., Khalturina E.O., Baranov I.I. Arterial hypertension as a consequence of endothelial glycocalyx dysfunction: a modern view of the problem of cardiovascular diseases. Cardiovascular Therapy and Prevention. 2022, Vol. 21, no. 9, pp. 3316.
- Pekhova K.A., Mikhin V.P., Gavrilyuk YE.V., Konoplya A.I. Immune and metabolic disturbances at the idiopathic hypertensia of various severity level. Journal of New Medical Technologies, 2012, Vol.19, no.1, pp. 172-173.
- Svidovskaya S.V., Mikhalevskaya N.A., Galchenkova O.S., Knyazeva L.A. Proinflammatory cytokinemia and stiffness of the arterial channel in nephrogenic hypertension. Bulletin of new medical technologies. 2012, Vol. XIX, no. 4, pp.126-127.
- Khusainova L.N., Islamgaleeva Z.M., Belyaeva I.G., Mingazetdinova L.N., Mutalova E.G. Expression of cytokine network in patients with cardiovascular diseases. Uspekhi sovremennostvennoy nauchnostvosnaniya. 2013, no. 3, pp. 2-30.Bernardo R.I., Hector P., Jonson R.J. Role of the immune system in hypertension. Physiol Rev. 2017, no. 97, pp. 1127-1164.
- Jaquet V., Leidal K., Perozzo R., Plastre O., Fioraso-Cartier L., Diebold B., Scapozza L., Nauseef W.M., Krause K.H., Bedard K. NADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action. British Journal of Pharmacology, 2011, no.164, pp. 507-520.
- Norlander A.E., Madhur M.S., Harrison D.G. The immunology of hypertension. J Exp Med. 2018, Vol. 215, no.1, pp. 21-33.